Tag Archives: Prof Olav Mella

Cancer doctor Dagfinn Øgreid has treated ME patients with rituximab

Blog article: Offers private ME treatment with cancer drugs – scientists react, by Anne Grete Storvik, Nov 23 2015 in Dagensmedicin [ translated by Google translate] A private clinic in Sandnes offers treatment for ME with the cancer drug rituximab. Patients pay … Continue reading

Posted in News | Tagged , , , , , , | 1 Comment

UK rituximab trial fundraising total almost reached

Invest in ME has announced the latest fundraising total for the rituximab/B-cell research, which is a great boost as the research team at UCL are about to visit and discuss the subject with Dr Fluge and Professor Mella in Haukeland University Hospital, … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on UK rituximab trial fundraising total almost reached

Elevated autoantibodies found in CFS subgroup

Research highlights: β adrenergic and muscarinic acetylcholine receptor autoantibodies are elevated in a subset of patients with Chronic Fatigue Syndrome (CFS). Elevated autoantibodies in CFS correlate with elevated IgG1-3 subclass levels, thyreoperoxidase and ANA antibodies and T cell activation. In … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on Elevated autoantibodies found in CFS subgroup

Norwegian Rituximab trial update

The Norwegian multicenter Rituximab study begins The long-awaited Norwegian phase III study of Rituximab as a treatment for ME/CFS is now getting off the ground. The study is led by the oncologists Prof Olav Mella and Dr Øystein Fluge at … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab trial update